Centre Georges-François Leclerc — Dijon, Côte d'Or

Public research footprint of Centre Georges-François Leclerc, compiled from the ClinicalTrials.gov public registry.

389

Registered studies

182

Active

Recruiting now

138

Completed

Stopped or withdrawn

Most-studied conditions

Non Small Cell Lung Cancer · Triple Negative Breast Cancer · Squamous Cell Carcinoma of Head and Neck · Head and Neck Cancer

Recently updated registry entries

NCT06393374 — Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not… (Recruiting)
NCT03412058 — Identifying the Predictive Factors of Response to PD-1 or PD-L1 Antagonists (Terminated)
NCT07106632 — Optimising Adjuvant Chemotherapy Prescription in Young Patients With Hormone-dependent… (Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Centre Georges-François Leclerc?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 04, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.